Skip to main content

Table 1 Clinical characteristics of patients enrolled in this study

From: Analysis of EGFR, KRAS, and PIK3CA gene mutation rates and clinical distribution in patients with different types of lung cancer

Characteristics

 

Number (%)

Age (year)

59.62 ± 9.82

221

≤60

112 (50.7)

>60

109 (49.3)

Gender

Male

114 (51.6)

Female

107 (48.4)

Pathological type

Squamous cell carcinoma

15 (6.8)

Adenocarcinoma

155 (70.1)

Adenosquamous carcinoma

7 (3.2)

Others

44 (19.9)

Staging

Stage IA

22 (10.0)

Stage IB

51 (23.1)

Stage IIA

8 (3.6)

Stage IIB

9 (4.1)

Stage IIIA

23 (10.4)

Stage IIIB

5 (2.3)

Stage IV

33 (14.9)

Undefined

70 (31.7)

Treatment

Surgery

67 (30.3)

Chemotherapy

37 (16.7)

Surgery + chemotherapy

66 (30.0)

Not available

51 (23.0)